MedTrace Logo

Cognitive Function and Addiction Under Opioid Tapering

NCT03365817 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2017-12-07

No results posted yet for this study

Summary

This study evaluates the effects of opioid dose reduction in the treatment of chronic pain in adults. Participants were divided in two groups: 1) patients that reduced opioid dose and 2) patients that kept the same opioid dose for six months.

Conditions

Interventions

DRUG

Opioids taper off

Decrease of 10% of opioid daily dose every one to two weeks until discontinuation for up to six months.

DRUG

Opioid stable treatment

No changes on prescribed opioids and adjuvant medication for the next six months

Sponsors & Collaborators

  • The Ministry of Science, Technology and Innovation, Denmark

    collaborator OTHER_GOV

  • Hørslev-Fonden

    collaborator UNKNOWN

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Per Sjøgren, DMSc · Rigshospitalet, Denmark

  • Jette Højsted, MD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-02
Primary Completion
2014-12-01
Completion
2014-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365817 on ClinicalTrials.gov